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Measles vaccine cannot give high sero-conversion rates in developing countries. The high
birth rates characteristic of these countries lead to infection at a very early age, thus making it
difficult to vaccinate before exposure to the disease. Nevertheless, ifgiven early in life, thevac-
cine can reduce the rate of virus circulation and thus raise the age at which children are in-
fected. Once that is done, higher sero-conversion rates can be obtained by raising the age at
vaccination. During the period when vaccine is given at an early age, the titers in responding
children will be low, and this will leave children of the next generation with little protection. It
is important, therefore, that ifvaccine is used early the program be intensively and consistently
applied to control virus circulation before the next generation is born.
Measles has been very largely controlled in the United States, but 13 percent ofall
1981 cases were attributable to importations [1] and, unless these can be prevented,
the disease cannot be eliminated. If the U.S. is to be freed of this disease, it cannot
act alone, but must work toward worldwide control. At this date, however, it is not
possible, with any available schedule ofimmunization, to protect a high proportion
of the measles-susceptible population in a densely populated developing country
(Fig. 1) [2-6]. In these countries, a large proportion of all measles cases occur early
in life, and if one waits long enough for most children to become responsive to the
vaccine by loss of maternal antibody, many will already have contracted the disease
and many will have died of it (Fig. 2A). It is possible to do somewhat better in
preventing measles cases than measles deaths, because the mortality is higher in the
earlier cases. Data on the total number of cases from poorer areas such as Pernam-
buco are too unreliable to be used as an illustration, but the limitation on vaccine ef-
fectiveness is evident even in data from Rio Grande do Sul, one of the most
developed parts of Brazil (Fig. 2B).
Re-vaccination at a later age is not a satisfactory solution to the problem of vac-
cine effectiveness in developing countries, because early vaccination inhibits the ef-
fect of a second dose [7-11], as well as because ofthe financial burden this places on
limited public health budgets. If effective control of measles is to be attained in
developing countries, a program must be designed to build on, and expand, herd im-
munity. Herd immunity, in the conventional sense of total protection of susceptible
individuals byimmunity in persons around them, is very difficult to establish against
measles, because the virus is extremely contagious and a very high level of popula-
tion immunity is required. However, population immunity affects the frequency of
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FIG. 1. Proportion ofchildren of different ages who developed measles hemagglutinin-inhibiting
antibody after vaccination. Sources: Kenya [1], Taiwan 121, Pernambuco (PE), Santiago, Chile
(CH), Para (PA), and Rio Grande do Sul (RS) [3]; U.S.A. combined data from [4-61.
virus transmission and, hence, the age at infection; the purpose ofthis paper is to ex-
amine the significance of this phenomenon.
Immunity to measles derives from two sources: active immunization resulting
from infection with wild or attenuated measles virus, and passive immunization by
transplacentally acquired antibody. Active immunization makes the more important
contribution to herd protection, but the duration of passive protection is quite
variable, and it is important in providing protection during the most vulnerable age.
PARAMETERS OF MEASLES ENDEMICITY IN THE
ABSENCE OF VACCINATION PROGRAMS
Reported cases of measles do not provide a satisfactory basis for calculating the
extent of natural active immunization. It can be assumed that, prior to introduction
of measles vaccine, everyone who lived more than a few years was infected with
measles, in most societies. Yet, in the United States the reported number ofmeasles
cases was less than 10 percent ofthe number ofbirths. In Mexico in 1972, it was only
3 percent, while in England and Wales, where reporting is possibly as good as
anywhere, it was 37 percent of births in 1970-73. On the other hand, more than 95
percent of the adults in most populations have measles antibody, and the age at
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FIG. 2. A: Line a, reported measles mortality accumulated by age, and line b, proportion of measles
deaths which could be prevented by vaccination at the indicated age. Data from Pernambuco, Brazil,
1979. B: Similar data for total reported measles in Rio Grande do Sul, an economically developed
part of Brazil. The predicted protection rate is extended beyond 12 months vaccination age on the
assumption of a 95 percent sero-conversion rate at age 15 months or more.
which this antibody is acquired provides a good indicator of the age at infection
[12].
Using serological data (Fig. 3) [12], we can estimate that the median age at infec-
tion was 6.0 years in New Haven, CT, in 1957, but only 2.0 years in Casablanca,
Morocco, or Guatemala City in 1953 and 1957, respectively. Thus, half of all
measles infections in the developing countries fell on children under two years old,
whereas only 12 percent of the reported cases of measles in the U.S. occurred in
children in this most vulnerable age group.
In some countries, differences in measles age-specific attack rates may be deter-
mined by differences in child-care practice, and consequent differences in frequency
of exposure of infants to the larger community. However, the differences in measles
age distribution, in the three areas mentioned above, are explicable simply on the
basis of the proportion of the population in the lower age groups. Bartlett [13] and
Griffiths [14] have shown that the number of measles cases per person in the popula-
tion under consideration, N, is proportional to the product of three terms: the frac-
tion ofthepopulation in the infectious stage ofdisease, I, the fraction ofthepopula-
tion susceptible to infection, S, and X, a measure of the facility with which the virus is
spread:
N = ISX
We can calculate S, the proportion susceptible, by summing, for each age group,
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FIG. 3. Accumulated percent of population with measles-neutralizing antibodies
in Casablanca, Morocco, in 1953, New Haven, CT, in 1957, and Guatemala City,
Guatemala, in 1959.
the product ofthe fraction without measles antibody, times the fraction ofthe whole
population in that age group. From this value one must subtract the number of
children possessing passive immunity. On the basis of the age at which 50 percent
sero-convert after vaccination (Fig. 1) the mean age at which children lose passive
protection can be estimated to be eight months in the U.S.A., and 5.5 months in
Kenya. The susceptible population in the developing countries is largely confined to
age strata less than five years old, but nevertheless, the numbers in these lower
cohorts are so great in Morocco and Guatemala, that the value of S, the proportion
of the population susceptible, is only moderately lower than in the U.S.A., where
susceptible individuals made up substantial proportions of all cohorts up to age ten
or twelve (Table 1).
TABLE 1
Demographic Parameters of the Endemic Measles Equilibrium in
the Pre-Vaccination Era
New Haven, Casablanca, Guatemala
CT, U.S.A. Morocco City, Guat.
Median age at acquisition ofantibody 6.0 2.0 2.0
% of population with antibody at
2nd birthday 12 50 50
S, proportion of population
susceptible 0.136 0.088 0.103
I, proportion of population
infectious 0.00090 .00136 .00168
X, relative transmission rate 1.0 1.02 0.71
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We can also estimate L If we assume that each case is infectious for two weeks,
and that everyone gets measles, the mean value of I will be two fifty-seconds part of
the annual birth rate, where that rate is expressed as a fraction of the total popula-
tion. Because of the high birth rate in developing countries [15], the value of Iwill be
high in those areas.
If we assume N was uniform in the several populations, because essentially
everyone ultimately caught measles, we can now use these values of I and S to
calculate relative values for X, the frequency of effective contact between infectious
and susceptible cases. The observed differences in X are small but, if anything,
measles seems to have spread less readily in Guatemala than elsewhere. These dif-
ferences cannot account for the more than fivefold greater proportion of children
infected at less than two years of age in the cities of developing countries. Rather,
the differences in age-specific attack rates were chiefly a result of differences in birth
rate.
THE SHORT-TERM EFFECTS OF A VACCINATION
PROGRAM IN A DEVELOPING COUNTRY
A vaccination program will have an immediate effect on the proportion of a
population that is susceptible to measles. The chance of an infected person contact-
ing a susceptible individual will then be reduced, and the rate of recruitment into the
infectious group decreased. In 1933, Hedrick [16] showed that in an endemic situa-
tion, the change in S from the beginning to the end of a measles epidemic is quite
small. The mean value at the beginning of an epidemic in Baltimore, during the early
1900s, was 12.6 percent of the whole population, and the epidemics ended when this
value had fallen to 10.4 percent (Fig. 4). A limited vaccination campaign could easily
effect this much change in the proportion susceptible and modify the normal se-
quence of measles epidemics. However, as pointed out earlier, vaccination programs
in developing countries cannot confer protection on all children at risk. Even in
relatively developed Rio Grande do Sul, the best response rate to be expected is
80 percent. It is probable that even a reasonably good campaign would miss 10 per-
cent of the Rio Grandense children, leaving a total of 28 percent unprotected. With
28 percent of the annual births entering the susceptible pool each year, the propor-
tion of the whole population susceptible will reach the level needed to sustain major
epidemics again within a decade.
There would be one important difference when the epidemics resumed: 28 per-
cent, instead of all the population, would experience measles. At the new equi-
librium, there would be only 28 percent of the previous number of infectious in-
dividuals in the community. Whereas, now the median Rio Grandense becomes
susceptible to measles at five months of age and is infected 19 months later, the me-
dian child could then expect to escape measles for six years. With this reduced inten-
sity of virus transmission, a smaller proportion of the children would be infected
while still in the most vulnerable age group, and the time of vaccine administration
could be raised to an age level when there would be less interference from residual
maternal antibody. It would then be possible to obtain much better response rates
and a successful long-term measles control program could be initiated.
LONG-TERM HAZARDS OF A POOR VACCINATION PROGRAM
I believe, that in this way, a consistent, well-orchestrated vaccination program
could control measles in any land. However, an erratic or inadequate program could
actually increase measles mortality. When a child is vaccinated while he still has
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marginal levels ofmaternal antibody, the effect ofthe vaccine is suppressed, but not
totally negated. We have recently studied the effect of re-vaccination in a group of
81 children who had first been vaccinated at six to twelve months of age without ap-
parent immunological response. All of 21 who were tested three weeks after re-
vaccination developed moderate titers of anti-measles IgG antibody, although all
but one were without IgM. However, when we tested these children three to eighteen
months after re-vaccination, their IgG levels had fallen precipitously, and in one out
of three the antibody titer was less than that which we usually find necessary to con-
fer protection. These dataconfirm similar findings made in the U.S.A. by Linneman
et al. [10]. Confirmation of the hypotheses that re-vaccination of initially pre-
maturely vaccinated children may fail to protect, was seen in the recent measles
epidemic in Westchester County, New York [11]. There, three of sixteen serologi-
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cally confirmed cases occurred in children who had been vaccinated twice, the first
time when they were less than thirteen months old.
We need not only be concerned about those children who may be made refractory
to re-vaccination by too early an attempt at immunization. Even when low residual
levels of passive antibody permit production of protective levels of immunity, this
antibody may still so inhibit the reaction to the vaccine, that titers of actively pro-
duced antibodies are suppressed. These low titers will protect the vaccine recipient,
but they may cause trouble for the next generation, because they will confer only
short-lived protection on the children of current vaccinees. I have already drawn at-
tention to the data which indicate that children in less developed areas generally
become responsive to measles vaccine sooner than children of most economically
privileged countries [1-3]. This early responsiveness is due to early loss of passive
protection, and it is indicative of early susceptibility to infection with wild measles
virus. The early age at acquisition of susceptibility is an important element in the
high measles mortality in less developed countries.
In the Greenland epidemics of 1951 to 1962 [17-18], maternal antibody was lack-
ing in all infants because the adults had not had measles. Data from these epidemics
can, therefore, be used to compare innate vulnerability to measles in the lower age
strata. We find that the case fatility rate in infants less than one year old, 3.8 per-
cent, was more than six times that in babies one to two years old and 53 times as high
as in older children (Table 2). Data fromvirgin-soil epidemics in South American In-
dians suggest that even among children less than one year old, there is avulnerability
gradient with the youngest at greatest risk [19-20]. Because of this gradient in case
fatality rate, earlier susceptibility in children of vaccinated mothers will leave them
at substantially increased risk.
The early loss ofpassive antibody, observed in developing countries, could be due
either to lower initial levels or to an increased rate ofdestruction. InTaiwan, a coun-
try in which measles vaccine response rates are characteristic of developing lands,
the mean measles antibody titers of mothers of small children were substantially
lower than in the United States (Table 3). These Taiwan women have less antibody
to pass to their babies and the babies would, therefore, become susceptible to
measles sooner. On the other hand, the rate of passive antibody decay observed in
Kenya, a 39-day half-life, is not more rapid than the rates suggested for the
developed countries [21-22].
TABLE 2
Age-Specific Measles Case Fatality Rate
in Greenland 1951-1962
Age No. ofCasesa Deaths Rate/1000
0-1 795 30 37.7
1-2 696 4 5.7
2-14 5628 4 0.7
14-34 5208 1 1 2.1
35-55 2713 24 8.8
55+ 1150 44 38.3
aIn distributing cases by age group it has
sometimes been necessary to assume that this
distribution was the same as in that ofthe popula-
tion as a whole.
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Maternal Protection in Taiwan and in Connecticut
Age with 80%o Response
Age of
Women 80% of Titers Expected Observed
(yr) Number G.M.T. Less Than: (mo) (mo)
Taiwan
25-38 75 47.5 160 7.6 6.5
19-24 42 50.4 160 7.6
Connecticut
24-29 50 226 640 10.2
13-19 50 143 320 9.2 10.6
Table 3 also gives mean titers for younger New Haven women. Those who were
born from 1961 to 1967 span the cohort in which the major immunizing agent
changed from wild to attenuated virus. Their titers are about half those of the older
age group. If half of them were immunized with vaccine and halfby wild virus, this
would indicate that the vaccine-induced titers are only one-quarter of those elicited
by wild virus. This estimate coincides well with the shorter term difference between
titers induced by these agents [23]. On this basis, we can expect that the children of
vaccinated mothers in this country will, in the future, be susceptible to measles two
months sooner than has been the case. It may be well to move the recommended age
for vaccination forward to 13 months of age, but as long as measles is controlled at
the present level, this situation should not present any serious problem.
When vaccine is given to age groups in which residual maternal antibody is
sometimes a problem, the titers in responding children are lowest in the youngest
(Fig. 5). The practice of vaccination at seven months of age, as was done in Rio
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Grande do Sul, results in a peak post-vaccinal titer of 25, one-quarter of that at-
tainable after the first birthday, and a fortieth of that commonly seen after wild
virus infection. These low titers are not due to immunological immaturity, but in-
dividually correlate inversely with the mother's titer [3]. Hence, they are probably
caused by very low residual levels of passively acquired antibody. When the girls
who are now being vaccinated in Southern Brazil grow to have babies of their own,
they will be able to confer protection on their offspring for only two or three
months, on the average. Many children will become susceptible even sooner. If the
circulation of measles virus has not been severely curtailed by that time, we must ex-
pect a serious increase in measles mortality.
In summary, a measles vaccination campaign can greatly reduce the toll exacted
by measles in developing countries, even when it is not possible to reach a high pro-
portion of susceptible children, provided the effect of herd immunity in raising the
age-specific attack rate is exploited. However, care must be taken, lest such a pro-
gram be inconsistently followed, and very young infants be left without either
maternal or herd immunity in the next generation.
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